AAAAAA

   
Results: 1-2 |
Results: 2
WHY DONT CANCER-PATIENTS GET ENTERED INTO CLINICAL-TRIALS - EXPERIENCE OF THE SHEFFIELD LYMPHOMA GROUPS COLLABORATION IN BRITISH NATIONAL LYMPHOMA INVESTIGATION STUDIES
Authors: HANCOCK BW AITKEN M RADSTONE C HUDSON GV
Citation: Bw. Hancock et al., WHY DONT CANCER-PATIENTS GET ENTERED INTO CLINICAL-TRIALS - EXPERIENCE OF THE SHEFFIELD LYMPHOMA GROUPS COLLABORATION IN BRITISH NATIONAL LYMPHOMA INVESTIGATION STUDIES, BMJ. British medical journal, 314(7073), 1997, pp. 36-37
ETOPOSIDE AND ACTINOMYCIN-D (EA) FOR METHOTREXATE (MTX) RESISTANT, LOW-RISK, PERSISTENT GESTATIONAL TROPHOBLASTIC DISEASE (GTD) AND EA WITHMTX (MEA) FOR HIGH-RISK GTD
Authors: LORIGAN PC NEVIN J RADSTONE C COLEMAN RE HANCOCK BW
Citation: Pc. Lorigan et al., ETOPOSIDE AND ACTINOMYCIN-D (EA) FOR METHOTREXATE (MTX) RESISTANT, LOW-RISK, PERSISTENT GESTATIONAL TROPHOBLASTIC DISEASE (GTD) AND EA WITHMTX (MEA) FOR HIGH-RISK GTD, European journal of cancer, 31A, 1995, pp. 1168-1168
Risultati: 1-2 |